<?xml version="1.0" encoding="UTF-8"?>
<p>As described in 
 <xref ref-type="sec" rid="sec10-viruses-11-01017">Section 10</xref>, Neurokinin-1 has been shown to be a potential receptor for MeV F. As an antagonist of Neurokinin-1, Aprepitant has been shown to drastically limit the viral dissemination of vaccine strain in the brain of CD46+/RAG-2ko mice [
 <xref rid="B96-viruses-11-01017" ref-type="bibr">96</xref>].
</p>
